|Blinn student finds normalcy years after double organ failure|
Now an 18-year-old student studying at Blinn College's Brenham campus, Jasmine Williams was seven when she was diagnosed with hyperoxaluria with oxalosis type 1, a rare genetic disorder caused by a liver deficiency that in turn attacks the kidneys.
Bryan-College Station Eagle - Sat, 08 Feb 2014 22:02
|Georges Gemayel Appointed new Chairman for OxThera|
"Primary Hyperoxaluria is a devastating disease and Oxabact® holds the promise to become the first therapy to be approved for its treatment. I am looking forward to working with Elisabeth Lindner and her team to bring this therapy to the patients as ...
SYS-CON Media (press release) - Thu, 13 Feb 2014 00:03
|Low-BP diet may offer advantages in cutting stone risk|
Researchers led by Nazanin Noori, MD, PhD, at the Hospital for Sick Children in Toronto examined the dietary interventions of 41 recurrent stone formers with hyperoxaluria over the course of 8 weeks. The intervention group followed a DASH-style diet ...
ModernMedicine - Mon, 03 Mar 2014 10:45
|Urology Product Preview March 2014|
Oxthera AB has initiated a placebo-controlled trial of its oral agent Oxabact for the treatment of primary hyperoxaluria. Oxabact is composed of highly concentrated freeze-dried live bacteria (Oxalobacter formigenes). Primary hyperoxaluria is a rare ...
ModernMedicine - Fri, 28 Feb 2014 17:46
|Team Matthew blood drive sets record, looks to expand efforts|
Matthew was born with primary hyperoxaluria Type 1, a rare genetic condition that left him in need of a kidney and liver transplant. He had to wait 15 months on a transplant list before receiving the organs. The Feb. 8 blood drive marked the beginning ...
Contra Costa Times - Tue, 25 Feb 2014 09:03
|Combined multi-organ transplant gives boy a new life|
The Class X student, was suffering from Primary hyperoxaluria, a rare medical condition which results in overproduction of oxalate in the body. This aids the formation of kidney stones, eventually leading to kidney failure. The only solution for boy's ...
Times of India - Sun, 23 Feb 2014 03:48
|State's First Multi-organ Transplant|
The New Indian Express - Sat, 22 Feb 2014 20:41
|Jefferies Starts Dicerna Pharmaceuticals (DRNA) at Buy|
"We see preclinical data for the lead program for primary hyperoxaluria, a rare liver/kidney disorder, as predictive of human benefit. DRNA's cancer programs are high risk. We expect critical human validation of both its technology and lead program in ...
StreetInsider.com (subscription) - Mon, 24 Feb 2014 04:00
|These Days, You Can't Spell Financings Of The Fortnight Without "IPO"|
It expects to start clinical trials for the treatment of primary hyperoxaluria in 2015, with proof-of-concept data due later that year. It also expects to advance DCR-M1711 for cancers driven by the MYC oncogene in the first half of 2014, with proof-of ...
The IN VIVO Blog (blog) - Fri, 07 Feb 2014 07:22